載入...
Optimizing the use of epidermal growth factor receptor inhibitors in advanced non-small-lung cancer (NSCLC)
Lung cancer is the leading cause of cancer-related death in US and Europe. Treatment with a platinum-based chemotherapy remains the standard of care, however with modest effect on quality of life and overall survival which seldom reaches 1 year. Recently, several classes of targeted agents have emer...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Pioneer Bioscience Publishing Company
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3256492/ https://ncbi.nlm.nih.gov/pubmed/22263061 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2010.12.05 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|